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(CoNS). This case–control study aimed to determine factors predicting deep sternal wound infections due to methicillin-resistant CoNS.
All cardiac surgery patients undergoing sternotomy between June 2009 and March 2013 prospectively documented in a Swiss tertiary
care center were included. Among 1999 patients, 82 (4.1%) developed deep sternal wound infection. CoNS were causal in 36 (44%)
patients, with 25/36 (69%) being methicillin resistant. Early reintervention for noninfectious causes (odds ratio (OR) 4.3; 95% conﬁdence
interval (CI) 1.9–9.5) was associated with methicillin-resistant CoNS deep sternal wound infection. Among CoNS deep sternal wound
infection, perioperative antimicrobial therapy (p 0.002), early reintervention for noninfectious causes (OR 7.9; 95% CI 0.9–71.1) and time
between surgery and diagnosis of infection over 21 days (OR 10.8; 95% CI 1.2–97.8) were associated with methicillin resistance. These
ﬁndings may help to better tailor preoperative antimicrobial prophylaxis.
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should be considered senior author.IntroductionSurgical site infections (SSI) in cardiac surgery with midline
sternotomy remain a major challenge. Reported incidence
varies between 2% and 14% for all SSI and between 2% to 4%
for deep sternal wound infections. Deep sternal wound in-
fections have a substantial impact on morbidity and mortality
and are associated with considerable costs [1–8]. Several riskNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artifactors for deep sternal wound infection have been described,
either related to comorbidities (e.g. diabetes and obesity) or
interventions (e.g. duration of surgery and reintervention)
[1,9–12].
The most common etiologic pathogens are Staphylococcus
aureus, coagulase-negative staphylococci (CoNS) and Gram-
negative bacteria [4,7,13–15]. In one study, infection control
interventions have been successful in reducing the rate of
sternal SSI caused by S. aureus, while the incidence of deep
sternal wound infection attributable to CoNS has not declined
in parallel [7].
Known risk factors for sternal SSI due to CoNS are length of
hospital stay before surgical intervention, duration of surgery
and reintervention at the same surgical site [15]. Intraoperative,
presumably airborne, transmission of CoNS from healthcare
workers to patients has been shown to occur [16,17]. In
addition, there is evidence that CoNS from clinical specimens
are closely related to one another at a hospital, interhospital or
even interregional level [18,19].New Microbe and New Infect 2015; 6: 15–21
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causing deep sternal wound infection in patients with heart
surgery involving sternotomy have not been deﬁned yet. Un-
derstanding these factors is important for infection control and
antibiotic prophylaxis policy, as routine prophylaxis recom-
mended by ofﬁcial guidelines does not cover SSI caused by
methicillin-resistant bacteria [20]. Furthermore, empirical
antimicrobial treatment in the case of an infection could be
more targeted in cases with presence of known risk factors.
We aimed to address this question by analysing a large pro-
spective cohort of cardiac surgery patients with midline ster-
notomy from a major Swiss university-afﬁliated tertiary care
center.MethodsSetting
The University Hospital Zurich is a tertiary care center with
942 beds. In 2012, 1166 patients underwent cardiac surgery,
including coronary artery bypass graft procedures, valve repairs
and replacements, heart transplantation and placement of
implantable cardiovascular devices, e.g. aortic grafts and ven-
tricular assist devices. Cefuroxime 1.5 g provided intravenously
with repetition every 8 hours in case of prolonged surgery is
the standard antibiotic prophylaxis for initial surgery and
reintervention.
Surveillance of SSI
All consecutive patients undergoing heart surgery at the Uni-
versity Hospital Zurich are included prospectively in the sur-
veillance protocol of the Swissnoso Surgical Site Infection
Surveillance Module (http://www.swissnoso.ch/), which is based
on the US Centers for Disease Control and Prevention deﬁ-
nitions [21]. As a modiﬁcation to the latter, sternal osteitis is
considered a deep incisional SSI even in the absence of
concomitant mediastinitis (http://www.swiss-noso.ch/wp-
content/uploads/2009/05/2_-D-30-09-2013_D_
Teilnehmerhandbuch_VERSION-UPDATE_SEPTEMBER-
20132.pdf).
Importantly, the protocol includes rigorous postdischarge
surveillance. All patients are contacted by phone 1 month after
the surgical intervention, or after 1 year if an implant, i.e. sternal
plate, wire cerclage, valve repair or replacement, was involved.
If suspicion for SSI arises, the case is further discussed with the
treating physician.
The data collected for each patient included the following:
sex, age, days between admission and surgery, timing of pre-
operative antibiotic prophylaxis, body mass index (BMI), wound
contamination class, American Society of AnesthesiologistsNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice(ASA) score, intervention exceeding 75th percentile of dura-
tion cut point [22] and reintervention. National Nosocomial
Infections Surveillance scores were calculated [22]. In case of
SSI, the depth of the infection, i.e. superﬁcial incisional, deep
incisional or organ/space, and the causing organisms were
recorded.
Case deﬁnition
All consecutive patients undergoing coronary artery bypass
graft procedures, valve repairs and replacements, or placement
of implantable cardiovascular devices, e.g. aortic grafts, ven-
tricular assist devices, between 1 June 2009 and 30 September
2013 were included, with the exception of minimally invasive
interventions. SSI surveillance was suspended between 1
January 2011 and 31 March 2011.
Deep sternal wound infection was deﬁned according to the
Swissnoso Surgical Site Infection Surveillance Module deﬁni-
tions (http://www.swiss-noso.ch/wp-content/uploads/2009/05/
2_-D-30-09-2013_D_Teilnehmerhandbuch_VERSION-
UPDATE_SEPTEMBER-20132.pdf). In brief, deep sternal
wound infection had to become manifest within 1 year after
surgery and had either to be conﬁrmed by a treating physician
or to be present with purulent drainage of the deep incisional
compartment or spontaneous wound dehiscence together with
pain, redness or temperature >38°C or a positive bacterial
culture from a deep tissue sample. Mediastinitis was deep
sternal wound infection with cultural, histologic or macroscopic
evidence of mediastinal involvement. Postoperative endocardi-
tis was not considered a deep sternal wound infection.
Besides the clinical criteria, CoNS etiology of deep sternal
wound infection required either a monoculture of CoNS from
at least one deep tissue sample. In polymicrobial deep sternal
wound infection, CoNS was only considered when additional
pathogens were Propionibacterium acnes or appeared in follow-
up cultures only. Antibiotic susceptibility was reported for the
ﬁrst CoNS isolated from the wound. Susceptibility testing was
done on Müller-Hinton agar (Becton-Dickinson, Franklin Lakes,
NJ, USA) using MacFarland 0.5 from overnight cultures fol-
lowed by incubation at 35°C for 16 to 18 hours. The disc
diffusion method according to Kirby-Bauer was applied for
susceptibility testing (http://www.eucast.org/antimicrobial_
susceptibility_testing/disk_diffusion_methodology/) using discs
from i2a (Montpellier, France). Inhibition zone diameters were
determined and recorded in the automated Sirweb/Sirscan
system (i2a) and interpreted according to EUCAST 1.3 guide-
lines from the European Committee on Antimicrobial Suscep-
tibility Testing using their breakpoint tables for interpretation of
minimum inhibitory concentrations and zone diameters, ver-
sions 1.3 and 2.0 (http://www.eucast.org/antimicrobial_
susceptibility_testing/previous_versions_of_tables/).European Society of Clinical Microbiology and Infectious Diseases, NMNI, 6, 15–21
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For cases of CoNS with deep sternal wound infection, a
retrospective chart review was performed and the following
additional information extracted: perioperative antibiotic
treatment, deﬁned as a course of therapeutic antibiotic not for
deep sternal wound infection (this had to be started, continued
or stopped in the 4 weeks before surgery until 2 weeks after
surgery); diabetes mellitus, deﬁned by any long-term oral or
injectable antidiabetic medication before surgery; and uni- or
bilateral internal mammary artery grafting.
Deﬁnition of factors evaluated for methicillin resistance
Factors were deﬁned as preoperative (sex, age, length of hos-
pital stay before surgery, BMI, diabetes, ASA score, time be-
tween antimicrobial prophylaxis and incision, contamination
class), intraoperative (duration of surgery and calculated t
score, grafting of bilateral internal mammary artery, grafts using
a venous bypass), perioperative (perioperative antibiotic as
deﬁned above) and postoperative (latency to diagnosis of deep
sternal wound infection, early reintervention within 1 month
for noninfectious complication).
Statistical analysis
For descriptive analyses, we used the chi-square or Fisher’s
exact test, as appropriate, for categorical data and the Mann-
Whitney U test for continuous variables. Univariable logistic
regression analysis was applied to calculate odds ratios (OR)
with 95% conﬁdence intervals (CI) in order to determine risk
factors for infection with methicillin-resistant CoNS in patients
with sternotomy and differences between infections with
methicillin-resistant CoNS and methicillin-sensitive CoNS. A
log-rank test was used to compare time to diagnosis in patients
with methicillin-resistant CoNS and methicillin-sensitive CoNS.
We used SPSS Statistics software, version 22 (IBM, Armonk,
NY, USA), for statistical analyses. A p value of <0.05 was
considered statistically signiﬁcant.
Ethics approval
SSI surveillance is considered to be a quality improvement
project and is therefore exempt from ethical approval. All pa-
tients were informed on the SSI surveillance at admission and
had the possibility to opt out.ResultsWe followed 2044 patients who underwent sternotomy be-
tween 1 June 2009 and 1 March 2013. As a result of incomplete
documentation, 45 patients were excluded. Of the remaining
1999 patients, 82 (4.1%) were diagnosed with a deep sternalNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiwound infection. In 36 (44%) cases, CoNS was the causative
microorganism and in 25/36 (69%) cases, CoNS were methi-
cillin resistant (Fig. 1). In 10/82 cases, S. aureus was found to be
the causative organism, while none of them was methicillin
resistant. Patient characteristics are shown in Table 1.
No difference was seen in pre- and intraoperative charac-
teristics between patients with methicillin-resistant CoNS and
the remainder of the study patients. Reintervention within 30
days for noninfectious causes was the only factor associated
with deep sternal wound infection due to methicillin-resistant
CoNS compared to patients without deep sternal wound
infection or those with deep sternal wound infection due to
other pathogens (OR 4.26; 95% CI 1.9–9.5; p 0.001).
Among patients with CoNS deep sternal wound infections,
perioperative therapeutic antibiotic treatment was associated
with methicillin resistance, as was consecutive reintervention
for noninfectious complications (Table 1).
Time from surgery to diagnosis of deep sternal wound
infection differed between cases with methicillin-sensitive
CoNS (median, 16 days) and cases with methicillin-resistant
CoNS (median, 23 days; χ2 [df 1] 4.37; p 0.037). Moreover,
diagnosis of deep sternal wound infection after 21 days was
strongly associated with methicillin-resistant CoNS (OR 10.8;
95% CI 1.2–97.8; p 0.016; Fig. 2).
Among the 82 patients with deep sternal wound infection, 15
(18%) had mediastinitis, which corresponds to 0.8% of all 1999
patients. Among the 36 cases with CoNS deep sternal wound
infection, 6 (17%) had mediastinitis.
Although all CoNS tested were susceptible to vancomycin,
methicillin-resistant CoNS were more often resistant to
trimethoprim/sulfamethoxazole (13/25; 52%) than methicillin-
sensitive CoNS (1/11; 9% p 0.016), while no difference was
found in resistance rates to clindamycin in methicillin-resistant
CoNS than in methicillin-sensitive CoNS (12/25; 48% vs. 2/11;
18%; p 0.09).DiscussionOur study suggests that in cardiac surgery with midline ster-
notomy, early surgical reintervention for noninfectious com-
plications is associated with deep sternal wound infection due
to methicillin-resistant CoNS. Among patients with CoNS deep
sternal wound infections, perioperative antibiotic therapy, early
surgical reintervention for noninfectious causes and occurrence
of deep sternal wound infection >21 days after surgery were
associated with methicillin resistance.
To our knowledge, our study is the ﬁrst to evaluate factors
associated with methicillin resistance in deep sternal wound
infection in terms of causing CoNS. The strict SSI surveillancelf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 6, 15–21
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
FIG. 1. Included and excluded study cases and controls. SSI, surgical site infection; CoNS, coagulase-negative staphylococci.
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sternotomy patients, which is also reﬂected in the high follow-
up rate of 98%. The drawbacks of our study were the retro-
spective analysis and the inherently limited number of infectious
outcomes. Therefore, performance of a multivariable regres-
sion analysis was not possible.
Early reintervention is a well-established risk factor for deep
sternal wound infection [15]. These patients usually have a
longer preoperative hospital stay, and as a consequence, they
might be colonized with methicillin-resistant CoNS rather than
methicillin-sensitive CoNS [23]. Moreover, reintervention
wound healing might be compromised as a result of scarring,
which increases the overall infection rate. Because reinter-
vention is frequently an emergent procedure and the chest has
already been opened before, standard aseptic procedure may
be challenged. Hypothetically, methicillin-resistant CoNS could
gain access to deep spaces during reintervention.
Among patients with CoNS deep sternal wound infections,
the association of methicillin resistance and perioperativeNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceantibiotic is not surprising. A single dose of antibiotics has been
shown to cause a marked increase of recovery of methicillin-
resistant CoNS from a patient’s skin [24]. This phenomenon
has been observed before. One study of methicillin-resistant
CoNS in cerebrospinal ﬂuid shunt infection suggested that
length of hospital stay before implantation was a risk factor and
hypothesized a predisposition by previous antibiotic therapy
[25]. Because perioperative antibiotic therapy was not recor-
ded in the prospective data set, we were unable to conclude
that perioperative antibiotic therapy was a risk factor for
methicillin-resistant CoNS deep sternal wound infection among
all study patients.
The time of diagnosis of methicillin-resistant and methicillin-
sensitive CoNS infections was different. Twenty-one days after
surgery, almost uniquely methicillin-resistant cases and not
methicillin-sensitive cases were detected. A previous study
examining early and late-onset mediastinitis observed differences
in presenting clinical features and themicrobial spectrum, but the
authors did not report on differences in methicillin resistance ofEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 6, 15–21
nses/by-nc-nd/4.0/)
TABLE 1. Patient characteristics
Characteristic
Methicillin-resistant
CoNSa
Methicillin-sensitive
CoNSa
Odds
ratiob pb
No methicillin-resistant
CoNSa
Odds
ratioc Pc
No. of patients 25 11 1974
Preoperative factor
Male sex 20/25 (80%) 9/11 (82%) 0.89 0.64 1421/1974 (72%) 1.58 0.248
Age, y 71 (38–81) 66 (48–85) NA 0.84 68 (15–90) NA 0.74
Time between admission and surgery, days 1 (1–8) 1 (1–4) NA 0.84 1 (0–55) NA 0.37
Time between preoperative antibiotic and incision, days 35 (0–125)d 35 (20–85) NA 0.90 40 (0–1145)e NA 0.59
Preoperative antibiotic within 1 hour before incision 21/25 (84%) 10/11 (91%) 0.53 0.59 1599/1974 (81%) 1.20 0.74
BMI, kg/m2 30 (17–35) 29 (18–38) NA 0.44 27 (14–71) NA 0.18
Diabetes mellitus 10/25 (40%) 2/11 (18%) 3.0 0.19 ND
ASA score 3 (3–4) 3 (2–4) NA 0.15 3 (1–5) NA 0.39
Contamination class of 1 25/25 (100%) 11/11 (100%) NA 1935/1974 (98%) NA NA
Intraoperative factor
ACBP with venous graft 9/25 (36%) 2/11 (18%) 2.53 0.25 651/1974 (33%) 1.12 0.47
ACBP with internal mammary artery 18/25 (72%) 5/11 (46%) 3.1 0.13 ND
ACBP with bilateral internal mammary artery 6/25 (24%) 3/11 (27%) 0.84 0.57 ND
Duration of surgery, minutes 246 (135–495) 250 (170–480) NA 0.66 260 (25–970) NA 0.48
NNIS score 1 (1–2) 1 (0–2) NA 0.57 1 (0–3) NA 0.28
Duration of surgery >75th percentile 11/25 (44%) 4/11 (36%) 1.38 .48 671/1974 (34%) 1.5 0.206
Perioperative factor
Perioperative antibiotics 13/25 (52%) 0/11 (0%) NA 0.002 ND
Postoperative factor
Reintervention 30 days after surgery for
noninfectious causes
11/25 (44%) 1/11 (9%) 7.9 .043 305/1974 (15%) 4.26 .001
Latency between surgery and diagnosis of deep
sternal wound infection with CoNS >21 days
13/25 (52%) 1/11 (9%) 10.8 0.016 NA
Data are presented as n/N (%) or median (range).
ACBP, aortocoronary bypass; BMI, body mass index; CoNS, coagulase-negative staphylococci; ASA, American Society of Anesthesiologists; NNIS, National Nosocomial Infections
Surveillance; NA, not applicable; ND, not determined.
aPatient groups according to occurrence and etiology of deep sternal wound infection.
bOdds ratio and p value comparing methicillin-resistant CoNS with methicillin-sensitive CoNS.
cOdds ratio and p value comparing methicillin-resistant CoNS with all study patients without methicillin-resistant CoNS.
d1/25 (4%) not determined before incision.
e121/1974 (6.1%) not determined before incision.
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methicillin-resistant strains or a predisposition for postoperative
wound contamination, with CoNS becoming increasingly resis-
tant during the hospital stay [23]. These hypotheses could not be
further evaluated because of the retrospective character of the
analysis. Another possibility is that methicillin-resistant CoNS
gain access to the wound only at reintervention, which could
explain the delay. Because of the small number of study patients,
multivariable analysis of the role of reintervention, perioperative
antibiotic treatment and delay >21 days on methicillin-resistant
CoNS was not possible. The later occurrence of methicillin-
resistant CoNS infections can therefore hardly be used to
curtail surgical prophylaxis, but it suggests that the chances of
ﬁnding methicillin-sensitive CoNS in deep sternal wound in-
fections diagnosed after 21 days after surgery are low.
Known risk factors for deep sternal wound infection—
elevated BMI, diabetes, prolonged duration of surgery, collec-
tion of bilateral internal mammary artery [27]—did not differ
between methicillin-sensitive and methicillin-resistant CoNS
cases, possibly as a result of a lack of statistical power. The
relatively high deep sternal wound infection incidence of 4.1% is
explained by a strict surveillance method. Moreover, when
applying the more conservative deﬁnition of deep sternal
wound infection requiring proof of mediastinitis, the infection
rate would be as low as 0.8%. We believe that for the purposesNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiof this study, considering sternal osteitis alone as deep sternal
wound infection was appropriate.
A meta-analysis demonstrated that glycopeptides alone are
no more effective than β-lactams for the prevention of SSI, and
its routine use has been discouraged [28]. Although the Society
of Thoracic Surgeons suggests the use of one or two doses of a
glycopeptide in cardiac surgery in combination with a β-lactam
as prophylaxis in certain situations such as graft implantations
[20], a more recent guideline by the American Society of
Health-System Pharmacists, the Infectious Diseases Society of
America, the Surgical Infection Society, and the Society for
Healthcare Epidemiology of America recommends the use of
vancomycin in cardiac surgery only in the case of penicillin al-
lergy [29]. Vancomycin use has been associated with an increase
of vancomycin-resistant enterococci in many studies, even
though when corrected for duration of hospitalization this as-
sociation may be small [30]. Nevertheless, addition of glyco-
peptide prophylaxis should preferably be limited to a
population at risk. This addition could be suitable as preoper-
ative prophylactic antibiotic for reinterventions. If this would
have been applied, 11 cases of methicillin-resistant CoNS could
have potentially been avoided in 316 early reinterventions
(3.5%; number needed to treat, 29). This is in contrast to po-
tential avoidance of 25 cases of methicillin-resistant CoNS
when applying a glycopeptide to the initial 1999 patients withlf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 6, 15–21
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
FIG. 2. Latency between surgery and diagnosis of deep sternal wound
infection with CoNS. Cumulative events of deep sternal wound infec-
tion with methicillin-sensitive CoNS and methicillin-resistant CoNS
according to latency (in days) between initial surgery and diagnosis. The
dashed line indicates day 21. Diagnosis of deep sternal wound infection
after this day was associated with methicillin resistance in etiologic
CoNS (odds ratio 10.8; p 0.02). CoNS, coagulase-negative
staphylococci.
20 New Microbes and New Infections, Volume 6 Number C, July 2015 NMNIsternotomy (1.3%; number needed to treat, 80). But because it
is not likely that all methicillin-resistant CoNS infections would
be avoided by a preoperative glycopeptide, the number needed
to treat would realistically be higher.
Factors associated with methicillin resistance within CoNS
cases (delayed diagnosis, perioperative antibiotic therapy)
cannot be generalized to all patients. Thus, no suggestion for
additional prophylaxis can be made.
In conclusion, we found that deep sternal wound infection
with methicillin-resistant CoNS was associated with early
reintervention. Among deep sternal wound infections with
CoNS, methicillin resistance was associated with early rein-
tervention and prior antibiotic treatment. A controlled pro-
spective study is needed to understand if an addition of a
glycopeptide as preoperative prophylaxis in this selected sub-
population of cardiac surgery patients would reduce the overall
SSI rate and that due to CoNS, especially those with methicillin
resistance. Further studies are also needed in regard to the
pathophysiology of CoNS deep sternal wound infection to
explain its delayed occurrence in those involving methicillin-
resistant CoNS.Conﬂict of interestNone declared.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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